News

Search:

Dutch Regulatory Authority Echoes Warning on Faulty Breast Implant Products

0 Likes

The Dutch Health Ministry is warning thousands of women about the risks associated with breast implant products manufactured by French firm Poly Implant Prothese (PIP) after becoming concerned about Read More...

Tags:

Breast Implant

Dutch

Health Ministry

Medical Device

Netherlands

PIP

Rupture

TGA: PIP Implants in Australia not Likely to Rupture

0 Likes

The Australian Therapeutic Goods Administration (TGA) today released statements indicating that, “there is no evidence of an increased rupture rate for PIP Poly Implant Prothese silicone gel breast Read More...

Tags:

AFSSAPS

Australia

France

Implants

ISO 14607

PIP

Poly Implant Prothese

Rupture

TGA

British Government Launches Investigation of PIP Implants

0 Likes

UK Health Secretary Andrew Lansley launched an investigation in to breast implants made by the now-bankrupt French Poly Implant Prothese (PIP) on 31 December, saying that he wants to “reassure women Read More...

Tags:

AFSSAPS

Andrew Lansley

Breast Implant

MHRA

PIP

Poly Implant Prothese

Rupture

Silicone

RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

Most Viewed
Most Popular

Most Viewed

China's SFDA Becomes CFDA amidst Consolidation of Power and New Leadership 25 March 2013
FDA Plans Huge Cardiovascular Registry With Focus on Medical Devices 2 April 2013
In Unprecedented Shift, EU Parliament Proposes Premarket Authorization for Medical Devices 15 April 2013
Goodbye, KFDA: Korean Regulator Gets New Name, Decentralized Authority After Reorganization 28 March 2013
FDA Gets Go-Ahead for Study of DTC Advertising and Social Media 18 April 2013
UPDATED: President's Budget Proposal Calls for Small Increases at FDA, but Big Changes for Industry 11 April 2013
IBM Awarded Huge Contract to Modernize Regulatory Review Processes at FDA 29 April 2013
New FDA Document Clarifies IND Process for Drugs, Biologics and Biosimilars 30 April 2013

New Regulatory Focus Apps for iPad and iPhone

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.

News

Dutch Regulatory Authority Echoes Warning on Faulty Breast Implant Products

TGA: PIP Implants in Australia not Likely to Rupture

British Government Launches Investigation of PIP Implants

Get RF Today